BMS-817399 / BMS  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BMS-817399 / BMS
ACTRN12609000788279: Ascending single and multiple oral doses of chemokine receptor 1 antagonist administered to healthy subjects

Completed
1
104
 
Bristol-Myers Squibb, Bristol-Myers Squibb
Rheumatoid arthritis
 
 

Download Options